Cross-Reactivity between Anisakis spp. and Wasp Venom Allergens (original) (raw)
Article navigation
Research Articles| February 13 2014
cALK-Abelló, Madrid, Spain
Search for other works by this author on:
aDepartments of Immunology and
Search for other works by this author on:
bAllergy, Hospital Carlos III, and
Search for other works by this author on:
bAllergy, Hospital Carlos III, and
Search for other works by this author on:
Int Arch Allergy Immunol (2014) 163 (3): 179–184.
Accepted:
December 16 2013
Published Online:
February 13 2014
Abstract
Background: Anisakiasis is caused by the consumption of raw or undercooked fish or cephalopods parasitized by live L3 larvae of nematode Anisakis spp. Larvae anchor to stomach mucosa releasing excretion/secretion products which contain the main allergens. It has been described that nematode larvae release venom allergen-like proteins among their excretion/secretion products. We investigated potential cross-reactivity between Anisakis and wasp venom allergens. Methods: Two groups of 25 patients each were studied: wasp venom- and Anisakis- allergic patients. Sera from patients were tested by ImmunoCAP, dot-blotting with recombinant Anisakis allergens and ADVIA-Centaur system with Hymenoptera allergens. Cross-reactivity was assessed by IgE immunoblotting inhibition assays. Role of cross-reactive carbohydrate determinants (CCDs) was studied by inhibition with bromelain and periodate treatment. Results: A total of 40% of wasp venom-allergic patients had specific IgE to Anisakis simplex and 20% detected at least one of the Anisakis recombinant allergens tested. Likewise, 44% of Anisakis- allergic patients had specific IgE to Vespula spp_._ venom and 16% detected at least one of the Hymenoptera allergens tested. Wasp venom-allergic patients detected CCDs in Anisakis extract and peptide epitopes on Anisakis allergens rAni s 1 and rAni s 9, whereas Anisakis- allergic patients only detected CCDs on nVes v 1 allergen from Vespula spp. venom. The only Anisakis allergen inhibited by Vespula venom was rAni s 9. Conclusions: This is the first time that cross-sensitization between wasp venom and Anisakis is described. CCDs are involved in both cases; however, peptide epitopes are only recognized by wasp venom-allergic patients.
References
Klimpel S, Palm HW, Rückert S, Piatkowski U: The life cycle of Anisakis simplex in the Norwegian Deep (northern North Sea). Parasitol Res 2004;94:1-9.
Audicana MT, Fernandez de Corres L, Munoz D, Fernandez E, Navarro JA, del Pozo MD: Recurrent anaphylaxis caused by Anisakis simplex parasitizing fish. J Allergy Clin Immunol 1996;96:558-560.
Audicana MT, Kennedy MW: Anisakis simplex: from obscure infectious worm to inducer of immune hypersensitivity. Clin Microbiol Rev 2008;21:360-379.
Kim JS, Kim KH, Cho S, Park HY, Cho SW, Kim YT, Joo KH, Lee JS: Immunochemical and biological analysis of allergenicity with excretory-secretory products of Anisakis simplex third-stage larva. Int Arch Allergy Immunol 2005;136:320-328.
Del Pozo MD, Audícana M, Diez JM, Munoz D, Ansotegui IJ, Fernández E, García M, Etxenagusia M, Moneo I, Fernández de Corres L: Anisakis simplex, a relevant etiologic factor in acute urticaria. Allergy 1997;52:576-579.
Murray J, Gregory WF, Gomez-Escobar N, Atmadja AK, Maizels RM: Expression and immune recognition of Brugia malayi VAL-1, a homologue of vespid venom allergens and Ancylostoma secreted proteins. Mol Biochem Parasitol 2001;118:89-96.
King TP, Wittkowski KM: Hyaluronidase and hyaluronan in insect venom allergy. Int Arch Allergy Immunol 2011;156:205-211.
Hotez P, Cappello M, Hawdon J, Beckers C, Sakanari J: Hyaluronidases of the gastrointestinal invasive nematodes Ancylostoma caninum and Anisakis simplex: possible functions in the pathogenesis of human zoonoses. J Infect Dis 1994;170:918-926.
Johansson E, Aponno M, Lundberg M, van Hage-Hamsten M: Allergenic cross-reactivity between the nematode Anisakis simplex and the dust mites Acarus siro, Lepidoglyphus destructor, Tyrophagus putrescentiae, and Dermatophagoides pteronyssinus. Allergy 2001;56:660-666.
Pascual CY, Crespo JF, San Martín S, Ornia N, Ortega N, Caballero T, Muñoz-Pereira M, Martin-Esteban M: Cross-reactivity between IgE-binding proteins from Anisakis, German cockroach, and chironomids. Allergy 1997;52:514-520.
Rodriguez-Perez R, Caballero ML, Gonzalez-Munoz M, Rodriguez-Mahillo A, Moneo I: Cloning and expression of a biologically active Anisakis simplex allergen Ani s 1 in the yeast Pichia pastoris. Mol Biochem Parasitol 2007;154:115-118.
Rodriguez-Perez R, Moneo I, Rodriguez-Mahillo A, Caballero ML: Cloning and expression of Ani s 9, a new Anisakis simplex allergen. Mol Biochem Parasitol 2008;159:92-97.
Caballero ML, Umpierrez A, Moneo I, Rodriguez-Perez R: Ani s 10, a new Anisakis simplex allergen: cloning and heterologous expression. Parasitol Int 2011;60:209-212.
Monsalve RI, Vega A, Marqués L, Miranda A, Fernandez J, Soriano V, Cruz S, Domínguez-Noche C, Sánchez-Morillas L, Armisen-Gil M, Guspí R, Barber D: Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization. Allergy 2012;67:528-536.
Caballero ML, Umpierrez A, Perez-Piñar T, Moneo I, de Burgos C, Asturias JA, Rodríguez-Pérez R: Anisakis simplex recombinant allergens increase diagnosis specificity preserving high sensitivity. Int Arch Allergy Immunol 2012;158:232-240.
Malandain H, Giroux F, Cano Y: The influence of carbohydrate structures present in common allergen sources on specific IgE results. Eur Ann Allergy Clin Immunol 2007;39:216-220.
Mertens M, Brehler R: Suitability of different glycoproteins and test systems for detecting cross-reactive carbohydrate determinant-specific IgE in hymenoptera venom-allergic patients. Int Arch Allergy Immunol 2011;156:43-50.
Vieths S, Jankiewicz A, Wüthrich B, Baltes W: Immunoblot study of IgE-binding allergens in celery roots. Ann Allergy Asthma Immunol 1995;75:48-55.
Bilò MB, Bonifazi F: The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy 2009;39:1467-1476.
Bousquet J, Anto JM, Bachert C, et al: Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 2006;61:671-680.
Saarne T, Grönlund H, Kull I, Almqvist C, et al: Cat sensitization identified by recombinant Fel d 1 several years before symptoms results from the BAMSE cohort. Pediatr Allergy Immunol 2010;21:277-283.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$45.00
1 Karger Article Bundle Token
$170
Rental